Dr. Lesley Stolz - BioTime
Dr. Lesley Stolz has been named Executive Vice President, Corporate Development at stem cell technology firm, BioTime.
Stolz, who comes to the firm from Sutro Biopharma where she was VP of Business Development, “will have primary responsibility for interactions with both investors and corporate partners,” said CEO Dr. Michael West.
“As we complete the building of our leading technology and intellectual property position in regenerative medicine and begin clinical trials with multiple products, Lesley will work with corporate partners and investors on the next stage of BioTime’s development.”